Many investors, especially more aggressive traders, look at lower-priced stocks as a way not only to make some good money but to get a higher share count.
Skeptics of low-priced shares should remember that at one point Amazon, Apple and Netflix traded in the single digits. Cogent Biosciences, which we featured last March, has tripled since then.
We screened our 24/7 Wall St. research database looking for smaller cap companies that could offer patient investors some huge returns for 2023 and beyond.
This post originally appeared at 24/7 Wall St.